INTRODUCTION
With the evolution of cutaneous oncology and dermatologic surgery, dermatologists have been increasingly called upon for the diagnosis and therapeutic management of rare tumors. 1 The development of angiosarcoma in chronic lymphedema was fi rst described by Stewart and Treves in 1948 in women with breast cancer treated with radical mastectomy. Literature also report cases of the syndrome in the lower extremities, in congenital, idiopathic, traumatic, infectious or post-surgical lymphedema. 2, 3 Early recognition of suspicious lesions in a lymphomatous limb and biopsy are essential, due to the poor prognosis of this entity, with a high rate of local recurrence, systemic dissemination and poor survival rate in fi ve years. 1, 4 
CASE REPORT
Female patient, 46 years old, with a history of bilateral lymphedema evolving for 28 years. CT was requested to screen distant metastasis and the patient was sent to a referral hospital in Oncology in the State.
DISCUSSION
Stewart-Treves syndrome (STS) is a rare syndrome associated with chronic lymphedema, classically described in the arm after radical mastectomy followed by radiation therapy. In 10% of cases it occurs in other locations, 2, 3 as in this case report, in which an unusual presentation in the lower limb was noted. STS represents 5% of cases of angiosarcomas, 5 with about 400 cases reported in the literature. It occurs most often between the fi fth and seventh decade of life.
Angiosarcomas are malignancies that originate from cells with endothelial function and morphology of blood or lymphatic vessels. In the presence of lymphoedema, they grow as plaques or cutaneous and subcutaneous nodules, single or multiple, which may coalesce, with an unknown etiology. Because it is a poorly differentiated neoplasms, it requires confi rmation by immunohistochemistry. 1, 3 The disease demonstrates positivity for endothelial cell markers such as factor VIII and anti-CD34 and anti-CD31 antibodies, the latter being the one with greater sensitivity and specifi city. 2, 4, 5 The infrequent occurrence of this disease and the innocuous appearance of the tumor lead to delays in diagnosis and treatment. Surgeries indicated for patients with malignant vascular tumors vary according to the possibility of preserving the member, and when preservation is not possible, the indicated procedure is the amputation, but radiotherapy and chemotherapy are also recommended. Angiosarcoma is a highly malignant tumor, both in its visceral location as in soft tissue, being the malignant vascular tumor with the worst prognosis. 2, 5 Patient survival is 19-31 months from 
